Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMEXHS LIMITED Capital/Financing Update 2020

Sep 6, 2020

65120_rns_2020-09-06_32124502-f136-42c1-9869-c3b93b6a62cf.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [103 x 78] intentionally omitted <==

7 September 2020

==> picture [116 x 30] intentionally omitted <==

ASX ANNOUNCEMENT

IMEXHS receives a purchase order for 6-year deal with Colsanitas, a Keralty company

Highlights

  • IMEXHS has received a purchase order from Colsanitas for a 6-year recurring revenue deal worth ~A$1.8m

  • New deal to increase IMEXHS’s ARR by ~A$300,000

  • Potential point of entry into a world-renowned healthcare company

IMEXHS Limited (ASX: IME) (“IMEXHS” or “the Company”) announces it has entered into a 6-year agreement with Colsanitas, part of Keralty, a Spanish global healthcare company.

The purchase order is worth ~A$1.8m and will increase IMEXHS’s ARR by ~A$300,000.

Keralty is a global leader in comprehensive healthcare. It operates over 15,000 healthcare centres across the world, of which 341 are owned directly by Keralty and eight of those are located in Colombia. Keralty operates under the Colsanitas and Medisanitas brands in Colombia which are highly respected prepaid medical companies, as well as under the health services provider brand EPS Sanitas.

The order is for IMEXHS to operate at one of Colsanitas’s latest acquisitions, Clinica Infantil Santa Maria del Lago, in Bogotá, Colombia. The hospital has more than 150 hospital beds, a radiology department, 19 critical paediatric care units, 18 critical adult care beds, a clinical laboratory and many other services. The hospital serves about 240,000 minors who are members of EPS Sanitas.

IMEXHS will provide its leading HIRUKO™ platform, including its Aquila RIS/PACS & patient portal solution as well as Nuance’s Voice Recognition software.

IMEXHS’s CEO Dr German Arango said “We are excited with this new endeavour as Colsanitas plans to open more clinics within Colombia which will provide IMEXHS with future opportunities. Our Aquila solution will enable Colsanitas radiologists to efficiently work from home during these unprecedented times by leveraging Aquila’s tele-radiology tools.”

Authorised for release by the board of IMEXHS Limited.

-ENDS-

For more information, please contact:

Media and Investor Relations

Françoise Dixon, Citadel-MAGNUS E: [email protected] T: +61 412 292 977

Business Inquiries

Tony Thomas – CFO IMEXHS E: [email protected] T: +61 (0)2-9030-0040

IMEXHS Limited ABN 60 096 687 839

Imaging Experts and Healthcare Services Pty Ltd ABN 18 624 772 756 122 O’Riordan Street, Mascot NSW 2020 Tel: +61 2 9030 0040

==> picture [103 x 78] intentionally omitted <==

==> picture [116 x 30] intentionally omitted <==

About IMEXHS

IMEXHS Limited [ASX: IME] is a leading imaging Software-as-a-Service (SaaS) and ancillary solutions provider with 227 customers and distributors in 15 countries. Founded in 2012, IMEXHS is known for its innovation in the imaging services market, offering flexible and scalable imaging solutions via its HIRUKO branded suite of solutions for next generation Picture Archiving and Communications System (PACS) and integrated medical imaging systems (including a Radiology Information System (RIS), a Cardiology Information System (CIS) and an Anatomical Pathology Laboratory Information System (APLIS)). The HIRUKO™ system is completely cloud-based, vendor neutral and zero footprint with no need for installed software. The IMEXHS products are designed to increase productivity and save money for end users, with a scalable platform that is configured for the future and enhances patient outcomes. For more information, visit www.imexhs.com

About Keralty

Keralty is the parent company of group of subsidiary companies that has developed a Comprehensive Health Model with the purpose of improving overall health and well-being. Keralty is committed to maintaining the health and independence of users. It focuses on the prevention, identification and management of health risks, as well as on the control and care of illnesses and dependence. In addition, it is a leader in comprehensive healthcare which is recognized for its humane, scientific, technical and ethical approach.

IMEXHS Limited ABN 60 096 687 839

Imaging Experts and Healthcare Services Pty Ltd ABN 18 624 772 756 122 O’Riordan Street, Mascot NSW 2020 Tel: +61 2 9030 0040